Mission-oriented translational cancer research - health economics

Mol Oncol. 2019 Mar;13(3):636-647. doi: 10.1002/1878-0261.12440. Epub 2019 Feb 20.

Abstract

Health economics is an integrated aspect of all phases of mission-oriented translational cancer research and should be considered an intrinsic component of any study aimed at improving outcomes for patients and intervention costs. Information about value and value for money of new options for prevention and treatment is needed for decisions about their adoption and use by healthcare systems.

Keywords: cancer policy; cancer research; health economics; translational cancer research.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / economics
  • Antineoplastic Agents / therapeutic use
  • Cost of Illness
  • Cost-Benefit Analysis
  • Delivery of Health Care / economics*
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / economics*
  • Translational Research, Biomedical / economics*

Substances

  • Antineoplastic Agents